ctrl K

Price Alert

Atea Pharmaceuticals Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

3.50

0.01 (0.29%)

At close: Aug 15, 2025, 3:59 PM

3.50

0.14%

After-hours: Aug 15, 2025, 04:10 PM EDT

Atea Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	64.7M	143.82M	188.46M	764.38M
Short-Term Investments	390.02M	434.28M	458.25M	n/a
Long-Term Investments	n/a	n/a	198K	305K
Other Long-Term Assets	197K	1.4M	1.49M	161K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	7.63M	12.35M	14.21M	n/a
Total Current Assets	462.36M	590.46M	660.92M	772.4M
Property-Plant & Equipment	2.12M	3.12M	4.09M	23K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.31M	4.51M	5.79M	489K
Total Assets	464.67M	594.97M	666.71M	772.89M
Account Payables	4.46M	4.25M	2.55M	4.53M
Deferred Revenue	n/a	n/a	n/a	-197K
Short-Term Debt	800K	760K	721K	197K
Other Current Liabilities	6.64M	20.91M	7.93M	45.37M
Total Current Liabilities	18.6M	32.38M	18.48M	56.88M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.36M	5.76M	5.25M	5.93M
Total Long-Term Liabilities	7.2M	7.4M	7.66M	5.93M
Total Liabilities	25.8M	39.78M	26.14M	62.81M
Total Debt	1.64M	2.4M	3.12M	197K
Common Stock	84K	83K	83K	83K
Retained Earnings	-364.22M	-195.84M	-59.88M	56.03M
Comprehensive Income	233K	207K	-684K	n/a
Shareholders Equity	438.87M	555.19M	640.57M	710.08M
Total Investments	390.02M	434.28M	458.25M	305K